A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer (TOGAR)
A Randomized, Open Labeled Phase II Pilot Study of Total Neoadjuvant Chemotherapy With FLOT ( FLOT-TNT) VS Standard Perioperative FLOT ( FLOTPOP) in Patients With Gastric or GEJ Cancer, and Assessment of CTDNA as Correlative Biological Response
Sponsor: Baylor College of Medicine
Terminated
Since activation, 3 subjects were enrolled but were ineligible for randomization to a treatment arm because of a positive diagnostic laparoscopy result. Given the repeat inability to enroll and randomize an eligible subject; accrual was halted.
Other terminated trials from Baylor College of Medicine
Other Gastric Adenocarcinoma trials with similar outcome
This PHASE2 trial investigates Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma and is currently terminated or withdrawn. Baylor College of Medicine leads this study, which shows 11 recorded versions since 2024 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Terminated PHASE2
-
May 2025 — Feb 2026 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jan 2025 — May 2025 [monthly]
Recruiting PHASE2
-
Sep 2024 — Jan 2025 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
▶ Show 6 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Feb 2024 — Apr 2024 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2023 — Feb 2024 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2023 — Sep 2023 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2022 — Apr 2023 [monthly]
Not Yet Recruiting PHASE2
-
Nov 2022 — Dec 2022 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Baylor College of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .